Participants were randomly allocated to receive subcutaneous semaglutide 1.0 mg once per week for 52 weeks or placebo (396 patients in each group). The researchers found that the estimated median ...

storage of an FFA tracer into subcutaneous fat depots together with its appearance rate in plasma VLDL-TG. The results of the present study support the potential role of the direct FFA uptake ...

Eight canines were randomized into two equal groups who received either 0.5 mg of semaglutide delivered via the RP or ...

Dr. Marc P. Bonaca can be reached by media at [email protected] or 303-860-9900. Dr. Marc Bonaca will present the study, "The Effect Of Once-weekly Subcutaneous Semaglutide On Functional Capacity In ...